Earlier this month, a phase 3 clinical trial of a new vaccine began in India.
Archive - March 2011
Big Pharma’s dependence on traditional executive compensation plans threatens to work in opposition
In the first two years after vaccination, oral vaccines have been proven to prevent up to 60 percent of new cholera cases, a new review has revealed.
Scientists have shown that an experimental vaccine against the human norovirus
Research from the Frederick S. Pardee Center for International Futures at the University of Denver’s Josef Korbel School of International Studies has found that
Alum is an adjuvant (immune booster) used in many common vaccines,